MRI Contrast Agents Market - Top Companies and Manufacturers

  • Report ID: 3139
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Companies Dominating the MRI Contrast Agents Landscape

    • Trivitron Healthcare
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • General Electric Company
    • Bayer AG
    • Lantheus Medical Imaging Inc.
    • Bracco Diagnostic Inc.
    • Daiichi Sankyo Company
    • Nano Therapeutics Pvt Ltd
    • Spago Nanomedical AB
    • Guerbet SA

Browse Key Market Insights with Data Illustration:

In the News


Author Credits:  Radhika Pawar


  • Report ID: 3139
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of MRI contrast agents is evaluated at USD 2.39 billion.

MRI Contrast Agents Market size was valued at USD 2.26 billion in 2024 and is set to exceed USD 5.38 billion by 2037, registering over 6.9% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is expected to account for largest revenue share by 2037, owing to increasing necessity for advanced diagnosis method to detect various disease indications such as neurological disorders, cancer, cardiovascular diseases, and others.

The major players in the market include Bayer AG, GE Healthcare, LLC, Guerbet GmbH, Bracco Imaging SpA, Miltenyi Biotec B.V. & Co. Kg, and more.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample